Rahul Shukla

A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which confer protection against antibody dependent enhancement in AG129 mice

Viswanathan Ramasamy, Upasana Arora, Rahul Shukla et al. · PLoS neglected tropical diseases · 2018 · 94 citations · Full text

Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo

Rahul Shukla, Ravi Kant Rajpoot, Upasana Arora et al. · Frontiers in Microbiology · 2018 · 38 citations · Full text

Dengue and Zika virus infections are enhanced by live attenuated dengue vaccine but not by recombinant DSV4 vaccine candidate in mouse models

Rahul Shukla, Hemalatha Beesetti, Julia A. Brown et al. · EBioMedicine · 2020 · 38 citations · Full text

Dengue envelope-based ‘four-in-one’ virus-like particles produced using Pichia pastoris induce enhancement-lacking, domain III-directed tetravalent neutralising antibodies in mice

Ravi Kant Rajpoot, Rahul Shukla, Upasana Arora et al. · Scientific Reports · 2018 · 35 citations · Full text

Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies

Ankur Poddar, Viswanathan Ramasamy, Rahul Shukla et al. · BMC Biotechnology · 2016 · 29 citations · Full text